CRNX
HealthcareCrinetics Pharmaceuticals, Inc.
$37.18+0.67 (+1.84%)
Prev Close
$36.51
Open
$36.66
High
$37.37
Low
$35.85
Volume
508.2K
Market Cap
$4.00B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Crinetics Pharmaceuticals, Inc. (CRNX) has been exclusively selling, with 0 insider purchases totaling $0.00 and 17 insider sales totaling $8.12M. The most recent insider transaction was by Okey Stephanie (director), who sold $238.0K worth of shares on Mar 4, 2026. Crinetics Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $4.00B.
Buys (12M)
0
$0.00
Sells (12M)
17
$8.12M
Net Activity
Net Seller
$8.12M
Active Insiders
8
last 12 mo
CRNX Price Chart
CRNX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026↗ | Okey Stephanie | director | Sell | 6,000 | $39.67 | $238.0K | 13,300 |
| Mar 4, 2026↗ | Schilke Tobin | officer: Chief Financial Officer | Sell | 13,426 | $39.67 | $532.6K | 78,121 |
| Jan 7, 2026↗ | Kalofonos Isabel | officer: Chief Commercial Officer | Sell | 2,500 | $55.00 | $137.5K | 834 |
| Jan 5, 2026↗ | Kalofonos Isabel | Chief Commercial Officer | Sell | 2,500 | $55.00 | $137.5K | 0 |
| Dec 1, 2025↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $45.02 | $225.1K | 0 |
| Nov 3, 2025↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $42.66 | $213.3K | 0 |
| Oct 1, 2025↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $41.81 | $209.1K | 0 |
| Sep 26, 2025↗ | Fust Matthew K | Director | Sell | 16,000 | $44.75 | $716.0K | 0 |
| Sep 26, 2025↗ | Struthers Richard Scott | President & CEO | Sell | 4,000 | $45.00 | $180.0K | 0 |
| Sep 2, 2025↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $32.10 | $160.5K | 0 |
| Aug 22, 2025↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 30,000 | $30.43 | $912.9K | 0 |
| Aug 20, 2025↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 6,492 | $29.18 | $189.4K | 0 |
| Jun 12, 2025↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 97,483 | $32.23 | $3.14M | 0 |
| Mar 19, 2025↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 5,770 | $34.20 | $197.4K | 0 |
| Mar 19, 2025↗ | Knight Jeff E. | Chief Operating Officer | Sell | 7,162 | $34.20 | $245.0K | 0 |
| Mar 19, 2025↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 2,515 | $34.20 | $86.0K | 0 |
| Mar 19, 2025↗ | Struthers Richard Scott | President & CEO | Sell | 17,338 | $34.20 | $593.0K | 0 |
| Feb 3, 2025↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $39.07 | $195.3K | 0 |
| Jan 3, 2025↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 15,000 | $52.09 | $781.4K | 0 |
| Dec 2, 2024↗ | Struthers Richard Scott | President & CEO | Sell | 10,000 | $57.57 | $575.7K | 0 |
| Nov 22, 2024↗ | Knight Jeff E. | Chief Operating Officer | Sell | 501 | $56.52 | $28.3K | 0 |
| Oct 3, 2024↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $54.63 | $785.3K | 0 |
| Sep 26, 2024↗ | Wilson Marc | CFO | Sell | 25,000 | $51.11 | $1.28M | 0 |
| Sep 10, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 1,035 | $51.50 | $53.3K | 0 |
| Aug 26, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $53.19 | $159.6K | 0 |
| Aug 12, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $47.68 | $143.0K | 0 |
| Jul 25, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $53.43 | $160.3K | 0 |
| Jul 25, 2024↗ | Wilson Marc | CFO | Sell | 19,056 | $53.88 | $1.03M | 0 |
| Jul 15, 2024↗ | Knight Jeff E. | Chief Operating Officer | Sell | 27,000 | $55.00 | $1.49M | 0 |
| Jul 15, 2024↗ | Wilson Marc | CFO | Sell | 25,000 | $55.00 | $1.38M | 0 |
| Jul 10, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $48.55 | $145.7K | 0 |
| Jul 5, 2024↗ | Hassard James | Chief Commercial Officer | Sell | 15,000 | $44.08 | $661.2K | 0 |
| Jul 3, 2024↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $44.87 | $645.0K | 0 |
| Jun 28, 2024↗ | Wilson Marc | CFO | Sell | 32,129 | $43.61 | $1.40M | 0 |
| Jun 26, 2024↗ | Knight Jeff E. | Chief Operating Officer | Sell | 956 | $44.38 | $42.4K | 0 |
| Jun 25, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $45.37 | $136.1K | 0 |
| Jun 24, 2024↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 9,500 | $45.73 | $434.4K | 0 |
| Jun 21, 2024↗ | Hassard James | Chief Commercial Officer | Sell | 15,000 | $44.66 | $669.9K | 0 |
| Jun 10, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $43.86 | $131.6K | 0 |
| May 28, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $47.49 | $142.5K | 0 |
| May 10, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $49.43 | $148.3K | 0 |
| May 8, 2024↗ | Struthers Richard Scott | President & CEO | Sell | 107,448 | $49.40 | $5.31M | 0 |
| Apr 15, 2024↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $44.47 | $639.3K | 0 |
| Apr 4, 2024↗ | Struthers Richard Scott | President & CEO | Sell | 40,951 | $49.17 | $2.01M | 0 |
| Mar 28, 2024↗ | Okey Stephanie | Director | Sell | 17,500 | $46.38 | $811.6K | 0 |
| Mar 22, 2024↗ | Knight Jeff E. | Chief Operating Officer | Sell | 32,359 | $44.31 | $1.43M | 0 |
| Mar 20, 2024↗ | Fust Matthew K | Director | Sell | 60,000 | $44.14 | $2.65M | 0 |
| Mar 20, 2024↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 15,089 | $44.06 | $664.8K | 0 |
| Mar 18, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,655 | $38.14 | $139.4K | 0 |
| Mar 18, 2024↗ | Hassard James | Chief Commercial Officer | Sell | 1,741 | $38.14 | $66.4K | 0 |
| Mar 18, 2024↗ | Knight Jeff E. | Chief Operating Officer | Sell | 4,283 | $38.14 | $163.4K | 0 |
| Mar 18, 2024↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 411 | $38.14 | $15.7K | 0 |
| Mar 18, 2024↗ | Struthers Richard Scott | President & CEO | Sell | 12,687 | $38.14 | $483.9K | 0 |
| Mar 18, 2024↗ | Wilson Marc | CFO | Sell | 10,925 | $41.17 | $449.8K | 0 |
| Jan 25, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $37.26 | $111.8K | 0 |
| Jan 10, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $37.65 | $113.0K | 0 |
| Jan 3, 2024↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $35.00 | $503.1K | 0 |
| Jan 2, 2024↗ | Wilson Marc | CFO | Sell | 10,000 | $35.47 | $354.7K | 0 |
| Dec 26, 2023↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $35.89 | $107.7K | 0 |
| Dec 21, 2023↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 9,583 | $34.57 | $331.3K | 0 |
| Dec 11, 2023↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $32.87 | $98.6K | 0 |
| Nov 27, 2023↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $31.84 | $95.5K | 0 |
| Nov 2, 2023↗ | Struthers Richard Scott | President & CEO | Sell | 200,000 | $30.56 | $6.11M | 0 |
| Nov 1, 2023↗ | Wilson Marc | CFO | Sell | 10,000 | $28.75 | $287.5K | 0 |
| Oct 17, 2023↗ | Krasner Alan Seth | Chief Medical Officer | Sell | 7,000 | $30.00 | $210.0K | 0 |
| Jul 11, 2023↗ | Struthers Richard Scott | President & CEO | Sell | 50,000 | $20.21 | $1.01M | 0 |
| Jun 20, 2023↗ | Wilson Marc | CFO | Sell | 30,922 | $19.97 | $617.4K | 0 |
| Jun 16, 2023↗ | Struthers Richard Scott | President & CEO | Sell | 50,000 | $20.81 | $1.04M | 0 |
| Jun 8, 2023↗ | Vivaldi Coelho Rogerio | Director | Buy | 5,000 | $22.06 | $110.3K | 0 |
| Apr 3, 2023↗ | Pizzuti Dana | Chief Development Officer | Sell | 12,500 | $16.09 | $201.1K | 0 |
| Mar 16, 2023↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 1,410 | $17.12 | $24.1K | 0 |
| Mar 16, 2023↗ | Knight Jeff E. | Chief Operating Officer | Sell | 587 | $17.12 | $10.0K | 0 |
| Mar 16, 2023↗ | Krasner Alan Seth | Chief Medical Officer | Sell | 1,687 | $17.12 | $28.9K | 0 |
| Mar 16, 2023↗ | Struthers Richard Scott | President & CEO | Sell | 4,628 | $17.12 | $79.2K | 0 |
| Mar 16, 2023↗ | Wilson Marc | CFO | Sell | 1,666 | $17.12 | $28.5K | 0 |
| Feb 1, 2023↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $19.59 | $61.2K | 0 |
| Jan 25, 2023↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 8,336 | $21.07 | $175.6K | 0 |
| Jan 17, 2023↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $18.00 | $56.3K | 0 |
| Jan 3, 2023↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $18.35 | $57.4K | 0 |
| Dec 15, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $16.00 | $50.0K | 0 |
| Dec 1, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $17.84 | $55.8K | 0 |
| Nov 15, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $18.72 | $58.5K | 0 |
| Nov 1, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $18.52 | $57.9K | 0 |
| Oct 17, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $17.73 | $55.4K | 0 |
| Oct 3, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $19.64 | $61.4K | 0 |
| Sep 15, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 4,168 | $21.01 | $87.6K | 0 |
| Sep 7, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 1,042 | $21.00 | $21.9K | 0 |
| Sep 1, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $18.59 | $58.1K | 0 |
| Jul 26, 2022↗ | Knight Jeff E. | Chief Operating Officer | Sell | 1,152 | $20.70 | $23.8K | 0 |
| Jul 13, 2022↗ | Fust Matthew K | Director | Sell | 5,700 | $20.96 | $119.5K | 0 |
| May 2, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,247 | $20.10 | $65.3K | 0 |
| Apr 18, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 5,664 | $25.81 | $146.2K | 0 |
| Apr 13, 2022↗ | Struthers Richard Scott | President & CEO | Sell | 138,643 | $26.83 | $3.72M | 0 |
| Apr 5, 2022↗ | Struthers Richard Scott | President & CEO | Sell | 21,357 | $25.34 | $541.2K | 0 |
| Apr 4, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 9,000 | $23.97 | $215.8K | 0 |
| Mar 31, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 8,328 | $21.43 | $178.5K | 0 |
| Mar 15, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,123 | $18.94 | $59.1K | 0 |
| Feb 28, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,123 | $19.73 | $61.6K | 0 |
| Feb 28, 2022↗ | Madan Ajay | Chief Development Officer | Sell | 9,000 | $19.88 | $178.9K | 0 |
| Feb 15, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,123 | $18.64 | $58.2K | 0 |
| Feb 7, 2022↗ | Madan Ajay | Chief Development Officer | Sell | 13,411 | $17.83 | $239.1K | 0 |
| Feb 1, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,123 | $18.79 | $58.7K | 0 |
| Jan 19, 2022↗ | Krasner Alan Seth | Chief Medical Officer | Sell | 6,700 | $21.21 | $142.1K | 0 |
| Jan 18, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 4,168 | $23.29 | $97.1K | 0 |
| Jan 3, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 7,168 | $28.02 | $200.8K | 0 |
| Dec 28, 2021↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $27.95 | $83.9K | 0 |
| Dec 15, 2021↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 5,668 | $24.14 | $136.8K | 0 |
| Dec 1, 2021↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 5,668 | $27.38 | $155.2K | 0 |
| Nov 15, 2021↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 7,168 | $27.01 | $193.6K | 0 |
| Nov 5, 2021↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 16,500 | $28.06 | $463.0K | 0 |
| Nov 1, 2021↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 5,668 | $24.79 | $140.5K | 0 |
| Nov 1, 2021↗ | Fust Matthew K | Director | Sell | 8,954 | $25.50 | $228.3K | 0 |
| Oct 27, 2021↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $24.00 | $72.0K | 0 |
| Oct 21, 2021↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 1,042 | $21.10 | $22.0K | 0 |
| Sep 8, 2021↗ | Fust Matthew K | Director | Sell | 6,046 | $25.50 | $154.2K | 0 |
| Sep 7, 2021↗ | Struthers Richard Scott | President & CEO | Sell | 30,000 | $25.00 | $750.0K | 0 |
| Jul 26, 2021↗ | Fust Matthew K | Director | Sell | 5,000 | $19.59 | $98.0K | 0 |
| Jul 19, 2021↗ | Fust Matthew K | Director | Sell | 5,000 | $19.50 | $97.5K | 0 |
| Jul 12, 2021↗ | Fust Matthew K | Director | Sell | 5,000 | $20.71 | $103.5K | 0 |
CRNX Insider Buying Activity
The following table shows recent insider purchases of Crinetics Pharmaceuticals, Inc. (CRNX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 8, 2023↗ | Vivaldi Coelho Rogerio | Director | Buy | 5,000 | $22.06 | $110.3K | 0 |
CRNX Insider Selling Activity
The following table shows recent insider sales of Crinetics Pharmaceuticals, Inc. (CRNX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026↗ | Okey Stephanie | director | Sell | 6,000 | $39.67 | $238.0K | 13,300 |
| Mar 4, 2026↗ | Schilke Tobin | officer: Chief Financial Officer | Sell | 13,426 | $39.67 | $532.6K | 78,121 |
| Jan 7, 2026↗ | Kalofonos Isabel | officer: Chief Commercial Officer | Sell | 2,500 | $55.00 | $137.5K | 834 |
| Jan 5, 2026↗ | Kalofonos Isabel | Chief Commercial Officer | Sell | 2,500 | $55.00 | $137.5K | 0 |
| Dec 1, 2025↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $45.02 | $225.1K | 0 |
| Nov 3, 2025↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $42.66 | $213.3K | 0 |
| Oct 1, 2025↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $41.81 | $209.1K | 0 |
| Sep 26, 2025↗ | Fust Matthew K | Director | Sell | 16,000 | $44.75 | $716.0K | 0 |
| Sep 26, 2025↗ | Struthers Richard Scott | President & CEO | Sell | 4,000 | $45.00 | $180.0K | 0 |
| Sep 2, 2025↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $32.10 | $160.5K | 0 |
| Aug 22, 2025↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 30,000 | $30.43 | $912.9K | 0 |
| Aug 20, 2025↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 6,492 | $29.18 | $189.4K | 0 |
| Jun 12, 2025↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 97,483 | $32.23 | $3.14M | 0 |
| Mar 19, 2025↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 5,770 | $34.20 | $197.4K | 0 |
| Mar 19, 2025↗ | Knight Jeff E. | Chief Operating Officer | Sell | 7,162 | $34.20 | $245.0K | 0 |
| Mar 19, 2025↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 2,515 | $34.20 | $86.0K | 0 |
| Mar 19, 2025↗ | Struthers Richard Scott | President & CEO | Sell | 17,338 | $34.20 | $593.0K | 0 |
| Feb 3, 2025↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $39.07 | $195.3K | 0 |
| Jan 3, 2025↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 15,000 | $52.09 | $781.4K | 0 |
| Dec 2, 2024↗ | Struthers Richard Scott | President & CEO | Sell | 10,000 | $57.57 | $575.7K | 0 |
| Nov 22, 2024↗ | Knight Jeff E. | Chief Operating Officer | Sell | 501 | $56.52 | $28.3K | 0 |
| Oct 3, 2024↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $54.63 | $785.3K | 0 |
| Sep 26, 2024↗ | Wilson Marc | CFO | Sell | 25,000 | $51.11 | $1.28M | 0 |
| Sep 10, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 1,035 | $51.50 | $53.3K | 0 |
| Aug 26, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $53.19 | $159.6K | 0 |
| Aug 12, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $47.68 | $143.0K | 0 |
| Jul 25, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $53.43 | $160.3K | 0 |
| Jul 25, 2024↗ | Wilson Marc | CFO | Sell | 19,056 | $53.88 | $1.03M | 0 |
| Jul 15, 2024↗ | Knight Jeff E. | Chief Operating Officer | Sell | 27,000 | $55.00 | $1.49M | 0 |
| Jul 15, 2024↗ | Wilson Marc | CFO | Sell | 25,000 | $55.00 | $1.38M | 0 |
| Jul 10, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $48.55 | $145.7K | 0 |
| Jul 5, 2024↗ | Hassard James | Chief Commercial Officer | Sell | 15,000 | $44.08 | $661.2K | 0 |
| Jul 3, 2024↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $44.87 | $645.0K | 0 |
| Jun 28, 2024↗ | Wilson Marc | CFO | Sell | 32,129 | $43.61 | $1.40M | 0 |
| Jun 26, 2024↗ | Knight Jeff E. | Chief Operating Officer | Sell | 956 | $44.38 | $42.4K | 0 |
| Jun 25, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $45.37 | $136.1K | 0 |
| Jun 24, 2024↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 9,500 | $45.73 | $434.4K | 0 |
| Jun 21, 2024↗ | Hassard James | Chief Commercial Officer | Sell | 15,000 | $44.66 | $669.9K | 0 |
| Jun 10, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $43.86 | $131.6K | 0 |
| May 28, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $47.49 | $142.5K | 0 |
| May 10, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $49.43 | $148.3K | 0 |
| May 8, 2024↗ | Struthers Richard Scott | President & CEO | Sell | 107,448 | $49.40 | $5.31M | 0 |
| Apr 15, 2024↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $44.47 | $639.3K | 0 |
| Apr 4, 2024↗ | Struthers Richard Scott | President & CEO | Sell | 40,951 | $49.17 | $2.01M | 0 |
| Mar 28, 2024↗ | Okey Stephanie | Director | Sell | 17,500 | $46.38 | $811.6K | 0 |
| Mar 22, 2024↗ | Knight Jeff E. | Chief Operating Officer | Sell | 32,359 | $44.31 | $1.43M | 0 |
| Mar 20, 2024↗ | Fust Matthew K | Director | Sell | 60,000 | $44.14 | $2.65M | 0 |
| Mar 20, 2024↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 15,089 | $44.06 | $664.8K | 0 |
| Mar 18, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,655 | $38.14 | $139.4K | 0 |
| Mar 18, 2024↗ | Hassard James | Chief Commercial Officer | Sell | 1,741 | $38.14 | $66.4K | 0 |
| Mar 18, 2024↗ | Knight Jeff E. | Chief Operating Officer | Sell | 4,283 | $38.14 | $163.4K | 0 |
| Mar 18, 2024↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 411 | $38.14 | $15.7K | 0 |
| Mar 18, 2024↗ | Struthers Richard Scott | President & CEO | Sell | 12,687 | $38.14 | $483.9K | 0 |
| Mar 18, 2024↗ | Wilson Marc | CFO | Sell | 10,925 | $41.17 | $449.8K | 0 |
| Jan 25, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $37.26 | $111.8K | 0 |
| Jan 10, 2024↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $37.65 | $113.0K | 0 |
| Jan 3, 2024↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $35.00 | $503.1K | 0 |
| Jan 2, 2024↗ | Wilson Marc | CFO | Sell | 10,000 | $35.47 | $354.7K | 0 |
| Dec 26, 2023↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $35.89 | $107.7K | 0 |
| Dec 21, 2023↗ | Pizzuti Dana | Chief Med and Dev Officer | Sell | 9,583 | $34.57 | $331.3K | 0 |
| Dec 11, 2023↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $32.87 | $98.6K | 0 |
| Nov 27, 2023↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $31.84 | $95.5K | 0 |
| Nov 2, 2023↗ | Struthers Richard Scott | President & CEO | Sell | 200,000 | $30.56 | $6.11M | 0 |
| Nov 1, 2023↗ | Wilson Marc | CFO | Sell | 10,000 | $28.75 | $287.5K | 0 |
| Oct 17, 2023↗ | Krasner Alan Seth | Chief Medical Officer | Sell | 7,000 | $30.00 | $210.0K | 0 |
| Jul 11, 2023↗ | Struthers Richard Scott | President & CEO | Sell | 50,000 | $20.21 | $1.01M | 0 |
| Jun 20, 2023↗ | Wilson Marc | CFO | Sell | 30,922 | $19.97 | $617.4K | 0 |
| Jun 16, 2023↗ | Struthers Richard Scott | President & CEO | Sell | 50,000 | $20.81 | $1.04M | 0 |
| Apr 3, 2023↗ | Pizzuti Dana | Chief Development Officer | Sell | 12,500 | $16.09 | $201.1K | 0 |
| Mar 16, 2023↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 1,410 | $17.12 | $24.1K | 0 |
| Mar 16, 2023↗ | Knight Jeff E. | Chief Operating Officer | Sell | 587 | $17.12 | $10.0K | 0 |
| Mar 16, 2023↗ | Krasner Alan Seth | Chief Medical Officer | Sell | 1,687 | $17.12 | $28.9K | 0 |
| Mar 16, 2023↗ | Struthers Richard Scott | President & CEO | Sell | 4,628 | $17.12 | $79.2K | 0 |
| Mar 16, 2023↗ | Wilson Marc | CFO | Sell | 1,666 | $17.12 | $28.5K | 0 |
| Feb 1, 2023↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $19.59 | $61.2K | 0 |
| Jan 25, 2023↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 8,336 | $21.07 | $175.6K | 0 |
| Jan 17, 2023↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $18.00 | $56.3K | 0 |
| Jan 3, 2023↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $18.35 | $57.4K | 0 |
| Dec 15, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $16.00 | $50.0K | 0 |
| Dec 1, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $17.84 | $55.8K | 0 |
| Nov 15, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $18.72 | $58.5K | 0 |
| Nov 1, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $18.52 | $57.9K | 0 |
| Oct 17, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $17.73 | $55.4K | 0 |
| Oct 3, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $19.64 | $61.4K | 0 |
| Sep 15, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 4,168 | $21.01 | $87.6K | 0 |
| Sep 7, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 1,042 | $21.00 | $21.9K | 0 |
| Sep 1, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,126 | $18.59 | $58.1K | 0 |
| Jul 26, 2022↗ | Knight Jeff E. | Chief Operating Officer | Sell | 1,152 | $20.70 | $23.8K | 0 |
| Jul 13, 2022↗ | Fust Matthew K | Director | Sell | 5,700 | $20.96 | $119.5K | 0 |
| May 2, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,247 | $20.10 | $65.3K | 0 |
| Apr 18, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 5,664 | $25.81 | $146.2K | 0 |
| Apr 13, 2022↗ | Struthers Richard Scott | President & CEO | Sell | 138,643 | $26.83 | $3.72M | 0 |
| Apr 5, 2022↗ | Struthers Richard Scott | President & CEO | Sell | 21,357 | $25.34 | $541.2K | 0 |
| Apr 4, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 9,000 | $23.97 | $215.8K | 0 |
| Mar 31, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 8,328 | $21.43 | $178.5K | 0 |
| Mar 15, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,123 | $18.94 | $59.1K | 0 |
| Feb 28, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,123 | $19.73 | $61.6K | 0 |
| Feb 28, 2022↗ | Madan Ajay | Chief Development Officer | Sell | 9,000 | $19.88 | $178.9K | 0 |
| Feb 15, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,123 | $18.64 | $58.2K | 0 |
| Feb 7, 2022↗ | Madan Ajay | Chief Development Officer | Sell | 13,411 | $17.83 | $239.1K | 0 |
| Feb 1, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,123 | $18.79 | $58.7K | 0 |
| Jan 19, 2022↗ | Krasner Alan Seth | Chief Medical Officer | Sell | 6,700 | $21.21 | $142.1K | 0 |
| Jan 18, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 4,168 | $23.29 | $97.1K | 0 |
| Jan 3, 2022↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 7,168 | $28.02 | $200.8K | 0 |
| Dec 28, 2021↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $27.95 | $83.9K | 0 |
| Dec 15, 2021↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 5,668 | $24.14 | $136.8K | 0 |
| Dec 1, 2021↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 5,668 | $27.38 | $155.2K | 0 |
| Nov 15, 2021↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 7,168 | $27.01 | $193.6K | 0 |
| Nov 5, 2021↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 16,500 | $28.06 | $463.0K | 0 |
| Nov 1, 2021↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 5,668 | $24.79 | $140.5K | 0 |
| Nov 1, 2021↗ | Fust Matthew K | Director | Sell | 8,954 | $25.50 | $228.3K | 0 |
| Oct 27, 2021↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $24.00 | $72.0K | 0 |
| Oct 21, 2021↗ | Betz Stephen F. | Chief Scientific Officer | Sell | 1,042 | $21.10 | $22.0K | 0 |
| Sep 8, 2021↗ | Fust Matthew K | Director | Sell | 6,046 | $25.50 | $154.2K | 0 |
| Sep 7, 2021↗ | Struthers Richard Scott | President & CEO | Sell | 30,000 | $25.00 | $750.0K | 0 |
| Jul 26, 2021↗ | Fust Matthew K | Director | Sell | 5,000 | $19.59 | $98.0K | 0 |
| Jul 19, 2021↗ | Fust Matthew K | Director | Sell | 5,000 | $19.50 | $97.5K | 0 |
| Jul 12, 2021↗ | Fust Matthew K | Director | Sell | 5,000 | $20.71 | $103.5K | 0 |
CRNX Insiders
Similar Stocks to CRNX
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B